Cargando…

Serum α-chlorofatty acid as a biomarker for baseline subclinical cardiovascular disease in systemic lupus erythematosus

Detalles Bibliográficos
Autores principales:	Mahieu, MA, Guild, C, Albert, CJ, Kondos, G, Carr, J, Edmundowicz, D, Ford, DA, Ramsey-Goldman, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467499/ http://dx.doi.org/10.1186/ar3956

Ejemplares similares

Soluble E-selectin may predict progression of subclinical atherosclerosis, as measured by coronary artery calcium score and aorta calcium score, in women with systemic lupus erythematosus
por: Lertratanakul, A, et al.
Publicado: (2012)

Adverse pregnancy outcomes and subsequent risk of cardiovascular disease in women with systemic lupus erythematosus
por: Lin, Pin, et al.
Publicado: (2014)

Adverse pregnancy outcomes and subsequent risk of cardiovascular disease in women with systemic lupus erythematosus
por: Lin, Pin, et al.
Publicado: (2014)

2-Chlorofatty Aldehyde Elicits Endothelial Cell Activation
por: McHowat, Jane, et al.
Publicado: (2020)

Endothelial Cell Protein Targeting by Myeloperoxidase-Derived 2-Chlorofatty Aldehyde
por: Shakya, Shubha, et al.
Publicado: (2022)

Inflammatory expression profiles in monocyte-to-macrophage differentiation in patients with systemic lupus erythematosus and relationship with atherosclerosis
por: Korman, Benjamin D, et al.
Publicado: (2014)

Nonlymphoma hematological malignancies in systemic lupus erythematosus
por: Lu, M, et al.
Publicado: (2012)

Lung cancer in systemic lupus erythematosus
por: Kale, M, et al.
Publicado: (2012)

Characterization of N-Acetyl Cysteine Adducts with Exogenous and Neutrophil-Derived 2-Chlorofatty Aldehyde
por: Shakya, Shubha, et al.
Publicado: (2023)

Subclinical cardiovascular abnormalities in patients with juvenile systemic lupus erythematosus
por: Canpolat, Nur, et al.
Publicado: (2011)

Native T1 mapping by cardiovascular resonance imaging detects subclinical cardiomyopathy in patients with systemic lupus erythematosus
por: Puntmann, Valentina O, et al.
Publicado: (2013)

Myeloperoxidase-derived hypochlorous acid targets human airway epithelial plasmalogens liberating protein modifying electrophilic 2-chlorofatty aldehydes
por: Shakya, Shubha, et al.
Publicado: (2022)

Blimp-1 and systemic lupus erythematosus
por: Diamond, Betty, et al.
Publicado: (2014)

Prevalence of angina in patients with systemic lupus erythematosus
por: Ishimori, ML, et al.
Publicado: (2012)

Cytokines in systemic lupus erythematosus, London, UK
por: Rahman, Anisur
Publicado: (2003)

Is prevention of systemic lupus erythematosus a goal?
por: Olsen, Nancy J, et al.
Publicado: (2014)

Development of targeted biologics for systemic lupus erythematosus
por: Lipsky, Peter E
Publicado: (2012)

Complement deficiencies and susceptibility to systemic lupus erythematosus revisited
por: Elkon, KB, et al.
Publicado: (2012)

Thinking toward improved treatments of systemic lupus erythematosus
por: Hahn, BH, et al.
Publicado: (2012)

Significance of cerebrovascular reactivity in patients with systemic lupus erythematosus
por: Lazar, Jason, et al.
Publicado: (2014)

Cancer risk factors in systemic lupus erythematosus: multivariate regression analysis in 16,409 patients
por: Bernatsky, Sasha, et al.
Publicado: (2014)

The role of a defective clearance in the pathogenesis of systemic lupus erythematosus
por: Franz, S, et al.
Publicado: (2004)

Neutrophils - a complex story in the pathogenesis of systemic lupus erythematosus
por: Lood, Christian, et al.
Publicado: (2014)

The opportunity and imperative for point-of-care diagnostics in systemic lupus erythematosus
por: Fritzler, Marvin J
Publicado: (2014)

High mortality in North American Natives with systemic lupus erythematosus
por: Peschken, Christine A, et al.
Publicado: (2014)

Periodontitis is associated with higher subclinical atherosclerosis in patients with systemic lupus erythematosus
por: Zamora‐Pasadas, Mónica, et al.
Publicado: (2022)

Preliminary population-based incidence and prevalence estimates of systemic lupus erythematosus: the California Lupus Surveillance Project
por: Dall'Era, Maria C, et al.
Publicado: (2014)

Type I Interferons Are Associated with Subclinical Markers of Cardiovascular Disease in a Cohort of Systemic Lupus Erythematosus Patients
por: Somers, Emily C., et al.
Publicado: (2012)

The Role of Circulating Regulatory T Cell Levels on Subclinical Atherosclerosis and Cardiovascular Risk Factors in Women with Systemic Lupus Erythematosus
por: García-Carrasco, Mario, et al.
Publicado: (2018)

Nucleosome is a necrosis inducer for lymphocytes: consequences in systemic lupus erythematosus
por: Decker, P, et al.
Publicado: (2001)

Major congenital anomalies in children born to women with systemic lupus erythematosus
por: Vinet, E, et al.
Publicado: (2012)

Clinical and immunological response to pneumococcal vaccination in pediatric systemic lupus erythematosus
por: Rigdon, D, et al.
Publicado: (2012)

Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis
por: Bernatsky, S, et al.
Publicado: (2011)

Sociodemographics and epidemiology of serious infections requiring hospitalization among adults with systemic lupus erythematosus and lupus nephritis, 2000 to 2006
por: Feldman, Candace H, et al.
Publicado: (2014)

Subclinical cerebrovascular cognitive function, and mood changes in patients with systemic lupus erythematosus
por: Shehata, Ghaydaa A, et al.
Publicado: (2010)

Cardiac Manifestations in Systemic Lupus Erythematosus: Clinical Correlates of Subclinical Echocardiographic Features
por: Mohamed, Alaa A. A., et al.
Publicado: (2019)

Serum interleukin-18 and its relationship with subclinical atherosclerosis in systemic lupus erythematosus
por: Rezaieyazdi, Zahra, et al.
Publicado: (2021)

Subclinical retinopathy in systemic lupus erythematosus patients – optical coherence tomography study
por: Mimier-Janczak, Małgorzata Karolina, et al.
Publicado: (2023)

Clinical and immunological effects of anti-TNF therapy in systemic lupus erythematosus (SLE)
por: Aringer, M, et al.
Publicado: (2003)

Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus
por: Ambrozic, A, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_kdgo7qkesp6hk3ot0essnga0e4